• Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends
Close Search
00
GBAF LogoGBAF Logo
  • Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends
GBAF Logo
  • Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking & Finance Review

Company

    GBAF Logo
    • About Us
    • Profile
    • Wealth
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2025 GBAF Publications Ltd - All Rights Reserved.

    ;
    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Business

    Posted By linker 5

    Posted on January 29, 2021

    Featured image for article about Business

    By Simon Jessop and Abhinav Ramnarayan

    LONDON (Reuters) – Classic boot brand Dr. Martens kicked off its London IPO in style on Friday, attracting bumper demand in a sale valuing the company at more than $5 billion that is likely to spur other British companies to follow suit.

    Dr. Martens’ share were up 19% in their market debut after the company priced the deal at the top of an indicative range at 370 pence, raising nearly 1.3 billion pounds and giving it a market capitalisation of 3.7 billion pounds ($5.07 billion).

    Dr. Martens, known for its chunky boots with yellow stitching, is the first of several British IPO candidates to hit the market, as issuers look to make up for 2020 when the spread of COVID-19 wreaked havoc on economies and dented stock market listing volumes in Europe.

    The IPO also marks a major win for Dr Martens majority owner, private equity firm Permira, which bought the company in 2014 for 380 million euros ($460.10 million).

    “We have been delighted by the strong levels of interest, engagement and support from such a high quality selection of institutional investors,” said Chief Executive Kenny Wilson.

    “The successful transformation of Dr. Martens is a great story, and what is even more exciting is the huge potential ahead.”

    Dr Martens could sell a further 52.5 million shares on top of the initial 350 million shares sold, following heavy demand. The offer was eight times oversubscribed, it said in a statement. Sale of the additional shares would mean 40.3% of its stock was publicly traded.

    The Dr Martens listing follows that of Polish locker business InPost, which listed in Amsterdam on Wednesday with a valuation of 9.5 billion euros ($11.50 billion) and jumped 20% on its debut.

    In Britain, e-card retailer Moonpig is also making preparations for a London IPO, while others such as Deliveroo and Darktrace are among companies expected to announce plans for substantial listings later in the year.

    The rapid spread of a new coronavirus variant is expected to hit economies in Britain and beyond, but the stock market has remained resilient and demand for tech and growth firms remains strong.

    Goldman Sachs and Morgan Stanley were joint global co-ordinators for Dr Martens IPO, and Barclays, HSBC, Bank of America and RBC Europe were joint bookrunners. Lazard was financial adviser.

    (Additional reporting by Julien Ponthus. Editing by Jane Merriman)

    Recommended for you

    • Thumbnail for recommended article

    • Thumbnail for recommended article

    • Thumbnail for recommended article

    Why waste money on news and opinions when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe